Search

Author/Creator Brunner, Daniela

1. P4‐039: Differences between TG2576‐ and APP/PS1 Mice in High‐Throughput Behavioral Screening Correlates with Differences in Brain Pathology. (1st July 2016)

Authors:
Hanania, Taleen; Havas, Daniel; Sabath, Emily; Kabitzke, Patricia; Mazella, Matthew; Cox, Kimberly; Berger, Jason; Windisch, Manfred; Brunner, Daniela; Alexandrov, Vadim
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 21
Page Start:
P1029
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. O2–07–02: Characterization of double transgenic mice, APPSLxhQC, exhibiting enhanced pyroGlu3‐beta‐amyloid formation to evaluate efficacy of glutaminyl cyclase (QC) inhibitors. (1st July 2013)

Authors:
Schilling, Stephan; Kurat, Stephan; Brunner, Daniela; Hutter‐Paier, Birgit; Demuth, Hans‐Ulrich
Journal:
Alzheimer's & dementia
Issue:
Volume 9:Supplement 4S(2013)Part 8
Page Start:
P328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P3‐068: Effects of Treatment With Doxycycline on Behavior, Neuroinflammation and Brain Pathology in the RTG‐4510 Mouse Model. (1st July 2016)

Authors:
Havas, Daniel; Windisch, Manfred; Kabitzke, Patricia; Sabath, Emily; Thiede, Lucinda; Mazella, Matthew; Brunner, Daniela; Alexandrov, Vadim; Hanania, Taleen
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 17
Page Start:
P843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Exploring Combination Therapies in AD: Additive Effects of the QPCT Inhibitor Varoglutamstat and Aducanumab on Aβ Pathology and Biomarkers In Vivo. (20th December 2022)

Authors:
Hoffmann, Torsten; Schenk, Mathias; Gnoth, Kathrin; Ilse, Victoria; Brunner, Daniela; Rahfeld, Jens‐Ulrich; Schilling, Stephan; Schaeffer, Michael
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 10
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex. (1st December 2020)

Authors:
Theilmann, Wiebke; Gericke, Birthe; Schidlitzki, Alina; Muneeb Anjum, Syed Muhammad; Borsdorf, Saskia; Harries, Timon; Roberds, Steven L.; Aguiar, Dean J.; Brunner, Daniela; Leiser, Steven C.; Song, Dekun; Fabbro, Doriano; Hillmann, Petra; Wymann, Matthias P.; Löscher, Wolfgang
Journal:
Neuropharmacology
Issue:
Volume 180(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗